The significance of the nuclear farnesoid X receptor (FXR) in β cell function

Islets

Volumn 4, Issue 5, 2012, Pages 333-338

  Düfer, Martina ^a,b   Hörth, Katrin ^a   Krippeit Drews, Peter ^a   Drews, Gisela ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

FXR; Insulin secretion; Nuclear receptor; Stimulus secretion coupling; cell

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; ADENOSINE TRIPHOSPHATE; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLESTEROL; FARNESOID X RECEPTOR; FATTY ACID; GUGGULSTERONE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; TAUROCHENODEOXYCHOLIC ACID; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID;

BILE ACID BLOOD LEVEL; BINDING AFFINITY; BINDING SITE; CONCENTRATION (PARAMETERS); ENERGY EXPENDITURE; ENZYME PHOSPHORYLATION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84871034835     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.22383     Document Type: Review

References (32)

1. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009; 89:147-91; PMID:19126757; http://dx.doi.org/10.1152/physrev.00010.2008.
2. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J 2006; 25:1419-25; PMID:16541101; http://dx.doi.org/10.1038/sj.emboj.7601049.
3. Cai SY, Xiong L, Wray CG, Ballatori N, Boyer JL. The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution. Am J Physiol Regul Integr Comp Physiol 2007; 293:R1400-9; PMID:17567710; http://dx.doi.org/10.1152/ajpregu.00781.2006.
4. Renga B, Mencarelli A, Vavassori P, Brancaleone V, Fiorucci S. The bile acid sensor FXR regulates insulin transcription and secretion. Biochim Biophys Acta 2010; 1802:363-72; PMID:20060466; http://dx.doi.org/10.1016/j.bbadis.2010. 01.002.
5. Düfer M, Hörth K, Wagner R, Schittenhelm B, Prowald S, Wagner TF, et al. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes 2012; 61:1479-89; PMID:22492528; http://dx.doi.org/10.2337/db11-0815.
6. Claudel T, Staels B, Kuipers F. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 2005; 25:2020-30; PMID:16037564; http://dx.doi.org/10.1161/01.ATV. 0000178994.21828.a7.
7. Popescu IR, Helleboid-Chapman A, Lucas A, Vandewalle B, Dumont J, Bouchaert E, et al. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett 2010; 584:2845-51; PMID:20447400; http://dx.doi.org/10.1016/j.febslet.2010.04.068.
8. Teodoro JS, Rolo AP, Palmeira CM. Hepatic FXR: key regulator of whole-body energy metabolism. Trends Endocrinol Metab 2011; 22:458-66; PMID:21862343; http://dx.doi.org/10.1016/j.tem.2011.07.002.
9. Yamagata K, Daitoku H, Shimamoto Y, Matsuzaki H, Hirota K, Ishida J, et al. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem 2004; 279:23158-65; PMID:15047713; http://dx.doi.org/10.1074/jbc. M314322200.
10. Ma K, Saha PK, Chan L, Moore DD. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 2006; 116:1102-9; PMID:16557297; http://dx.doi.org/10.1172/JCI25604.
11. Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME, et al. Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology 2005; 146:984-91; PMID:15564327; http://dx.doi.org/10.1210/en. 2004-0965.
12. Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A 2006; 103:1006-11; PMID:16410358; http://dx.doi.org/10.1073/pnas.0506982103.
13. Prawitt J, Caron S, Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep 2011; 11:160-6; PMID:21431855; http://dx.doi.org/10.1007/s11892-011-0187-x.
14. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, et al. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 2006; 281:11039-49; PMID:16446356; http://dx.doi.org/10.1074/jbc.M510258200.
15. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, et al. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 2004; 53:890-8; PMID:15047603; http://dx.doi.org/10.2337/ diabetes.53.4.890.
16. Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, et al. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 2011; 60:1861-71; PMID:21593203; http://dx.doi.org/10.2337/db11-0030.
17. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Häring HU, et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 2009; 296:E384-93; PMID:19066319; http://dx.doi.org/10.1152/ajpendo.90748.2008.
18. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008; 4:214; PMID:18682704; http://dx.doi.org/10.1038/msb.2008.50.
19. Staels B, Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 2007; 67:1383-92; PMID:17600387; http://dx.doi.org/10. 2165/00003495-200767100-00001.
20. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10:167-77; PMID:19723493; http://dx.doi.org/10.1016/j.cmet.2009.08.001.
21. Rafferty EP, Wylie AR, Hand KH, Elliott CE, Grieve DJ, Green BD. Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R(-/-) mice. Biol Chem 2011; 392:539-46; PMID:21521075; http://dx.doi.org/10.1515/bc.2011.050.
22. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87:1409-39; PMID:17928588; http://dx.doi.org/10.1152/physrev.00034.2006.
23. Kok T, Hulzebos CV, Wolters H, Havinga R, Agellon LB, Stellaard F, et al. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J Biol Chem 2003; 278:41930-7; PMID:12917447; http://dx.doi.org/10.1074/jbc.M306309200.
24. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E, et al. Lowering bile acid pool size with a synthetic FXR agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem 2011; 286:26913-20; PMID:21632533; http://dx.doi.org/10.1074/jbc.M111.248203.
25. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439:484-9; PMID:16400329; http://dx.doi.org/10. 1038/nature04330.
26. Lee J, Seok S, Yu P, Kim K, Smith Z, Rivas-Astroza M, et al. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice. Hepatology 2012; 56:108-17; PMID:22278336; http://dx.doi.org/10.1002/hep.25609.
27. Herrema H, Meissner M, van Dijk TH, Brufau G, Boverhof R, Oosterveer MH, et al. Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice. Hepatology 2010; 51:806-16; PMID:19998408; http://dx.doi.org/10.1002/ hep.23408.
28. Bass JY, Caravella JA, Chen L, Creech KL, Deaton DN, Madauss KP, et al. Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene. Bioorg Med Chem Lett 2011; 21:1206-13; PMID:21256005; http://dx.doi.org/10.1016/j.bmcl.2010.12.089.
29. Lew JL, Zhao A, Yu J, Huang L, De Pedro N, Peláez F, et al. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J Biol Chem 2004; 279:8856-61; PMID:14684751; http://dx.doi.org/10.1074/jbc.M306422200.
30. Hart AW, Baeza N, Apelqvist A, Edlund H. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature 2000; 408:864-8; PMID:11130726; http://dx.doi.org/10.1038/35048589.
31. Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, Dina C, Hamid YH, Joly E, et al. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci U S A 2005; 102:4807-12; PMID:15774581; http://dx.doi.org/10.1073/pnas.0409177102.
32. Seghers V, Nakazaki M, DeMayo F, Aguilar-Bryan L, Bryan J. Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion. J Biol Chem 2000; 275:9270-7; PMID:10734066; http://dx.doi.org/10.1074/jbc.275.13. 9270.